WPI 3636 (Trospium chloride extended-release 60 mg)
Pill imprint WPI 3636 has been identified as Trospium chloride extended-release 60 mg.
Trospium is used in the treatment of overactive bladder; interstitial cystitis; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Trospium 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 3636
- Strength:
- 60 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
More about trospium
Consumer resources
- Other brands: Sanctura, Sanctura XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
